Opportunity Information: Apply for RFA CA 11 006

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Community Clinical Oncology Program Groups (U10)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.399 Cancer Control.
  • This funding opportunity was created on May 24, 2011 and posted on May 24, 2011.
  • Applicants must submit their applications by Jul 27, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $14,300,000.00 to eligible and selected applicants.
  • Eligible applicants include: For profit organizations other than small businesses Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non U.S.) components of U.S. Organizations are not allowed.
Apply for RFA CA 11 006

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Community Clinical Oncology Program Groups (U10) funding opportunity (RFA-CA-11-006) is a National Institutes of Health, National Cancer Institute cooperative agreement aimed at strengthening and expanding the NCI-supported Community Clinical Oncology Program (CCOP) Network through organizations that function as "accrual groups." In practical terms, the program is designed to support institutions and community-based oncology partners that can enroll (accrue) patients and participants into NCI-supported clinical trials and related research, especially in settings outside major academic medical centers. CCOP, originally established in 1983, was built around the idea that high-quality cancer clinical research should be conducted where many patients actually receive care: in the community. This FOA focuses on enabling community oncology systems to participate meaningfully in state-of-the-art cancer prevention, cancer control, and cancer treatment trials, while also helping research findings move faster into routine clinical practice.

The core goals of the CCOP Network described in the announcement center on three connected outcomes. First, the network seeks to accelerate the development of interventions that prevent or treat cancer, as well as interventions that address cancer-related symptoms, by increasing enrollment into clinical trials. Higher accrual generally means trials can answer research questions sooner and with stronger evidence, which can speed improvements in care. Second, the network aims to foster higher quality cancer care in community settings by promoting the adoption of results generated from clinical trials. The underlying concept is that when community clinicians are active partners in trials, it becomes easier to implement evidence-based practices locally once results are available. Third, the CCOP Network emphasizes increasing participation of minority and underserved populations in cancer clinical trials and associated research, reflecting longstanding concerns that clinical research participation often does not match the diversity of the populations affected by cancer. By supporting community-based accrual groups, the program intends to reduce barriers to participation and improve the representativeness of research findings.

From an administrative standpoint, this opportunity uses a cooperative agreement mechanism (U10), which typically indicates substantial programmatic involvement by the funding agency compared with a standard grant. While the announcement text provided does not spell out operational details, the cooperative agreement structure usually means awardees work closely with NCI staff on expectations such as trial activation, performance metrics, reporting, and adherence to network policies and procedures. The FOA notes that the CCOP Network has three components and that each component has its own separate FOA, positioning this particular announcement specifically for CCOP "Groups" serving as accrual organizations within the broader network.

The opportunity was posted on May 24, 2011, with an original and current closing date of July 27, 2011, and it was archived on August 27, 2011. The estimated total funding listed is $14,300,000. It falls under the broad activity areas of education and health, and it is associated with multiple CFDA program areas tied to the cancer research continuum: 93.393 (Cancer Cause and Prevention Research), 93.394 (Cancer Detection and Diagnosis Research), 93.395 (Cancer Treatment Research), and 93.399 (Cancer Control). The announcement indicates there is no cost-sharing or matching requirement, meaning applicants are not required to commit their own funds as a condition of the award.

Eligibility is broad across U.S.-based organizational types, including public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), and for-profit organizations other than small businesses. The eligibility language also explicitly includes a wide range of community-focused and mission-driven institutions such as faith-based or community-based organizations, regional organizations, and eligible federal agencies. It further calls out specific categories of institutions often emphasized in federal capacity-building and equity efforts, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities (TCCUs), and tribal governments and tribal organizations (including federally recognized tribal governments and other tribal government structures). U.S. territories or possessions are also included as eligible. At the same time, the FOA clearly excludes non-U.S. entities: foreign organizations are not eligible to apply, and foreign components of U.S. organizations are not allowed, reinforcing that the supported accrual and operations are intended to be domestic.

Overall, this FOA is best understood as an effort to expand the reach and impact of NCI clinical research by formally integrating community oncology practices and their patient populations into a national clinical trials infrastructure. The emphasis on accrual, translation of trial results into community care, and increased inclusion of minority and underserved populations signals that applicants were expected not only to enroll participants effectively, but also to demonstrate the capability to deliver high-quality research participation in real-world community settings and to strengthen equitable access to trials. For full details, the announcement directs applicants to the NIH Grants Guide posting for RFA-CA-11-006 and provides NIH Office of Extramural Research webmaster contacts for technical access issues.

Frequently Asked Questions (FAQs): Community Clinical Oncology Program Groups (U10) - RFA-CA-11-006

What is this funding opportunity?

This is a National Institutes of Health (NIH), National Cancer Institute (NCI) cooperative agreement funding opportunity for the Community Clinical Oncology Program (CCOP) Groups using the U10 activity code. The specific announcement is RFA-CA-11-006.

What is the purpose of the CCOP Groups (U10) program described here?

The purpose is to strengthen and expand the NCI-supported CCOP Network by supporting organizations that function as "accrual groups" (organizations that can enroll patients and participants) into NCI-supported clinical trials and related cancer research, particularly in community-based care settings rather than only major academic medical centers.

What does "accrual group" mean in this context?

In this context, an accrual group is an organization (often working with community-based oncology partners) that enrolls patients and other participants into NCI-supported clinical trials and related research studies.

Why does the program emphasize community-based settings?

The CCOP model was created around the idea that high-quality cancer clinical research should occur in the places where many patients actually receive care: in the community. This opportunity supports meaningful participation of community oncology systems in NCI-supported prevention, control, and treatment trials and aims to help research findings move more quickly into routine practice.

What are the core goals of the CCOP Network described in the announcement?

The announcement highlights three connected outcomes: (1) accelerating development of cancer-related interventions by increasing enrollment into clinical trials; (2) improving quality of cancer care in community settings by promoting adoption of trial results; and (3) increasing participation of minority and underserved populations in clinical trials and related research.

How does increasing enrollment (accrual) help cancer research?

Higher accrual generally allows clinical trials to reach their enrollment targets sooner, which can help studies answer research questions faster and with stronger evidence. That can speed progress toward improved cancer prevention, symptom management, control, and treatment approaches.

How does participation in trials relate to improving community cancer care?

The opportunity reflects the idea that when community clinicians and systems actively participate in clinical trials, it may be easier to adopt evidence-based practices locally after trial results are available, which supports higher quality cancer care in community settings.

Does the program specifically address inclusion of minority and underserved populations?

Yes. A stated emphasis of the CCOP Network is to increase participation of minority and underserved populations in cancer clinical trials and associated research. Supporting community-based accrual groups is presented as a way to reduce barriers and improve how well study participants reflect the populations affected by cancer.

What funding mechanism is used?

The opportunity uses a cooperative agreement mechanism (U10), which typically indicates substantial programmatic involvement by the funding agency compared with a standard grant.

What does the cooperative agreement structure imply for awardees?

While the provided text does not list operating details, it states that U10 cooperative agreements typically involve substantial programmatic involvement by NCI. This commonly includes close work with NCI staff around expectations such as trial activation, performance metrics, reporting, and adherence to network policies and procedures.

Is this FOA the only part of the CCOP Network funding?

No. The announcement notes that the CCOP Network has three components and that each component has its own separate FOA. This particular FOA is specifically for CCOP "Groups" that serve as accrual organizations within the broader network.

Which types of clinical trials or research areas are included?

The program description emphasizes participation in NCI-supported cancer prevention, cancer control, and cancer treatment trials, as well as research addressing cancer-related symptoms. The associated CFDA program areas also span cancer cause and prevention, detection and diagnosis, treatment, and control.

What are the CFDA numbers associated with this opportunity?

The opportunity is associated with multiple CFDA program areas: 93.393 (Cancer Cause and Prevention Research), 93.394 (Cancer Detection and Diagnosis Research), 93.395 (Cancer Treatment Research), and 93.399 (Cancer Control).

What are the activity areas for this opportunity?

The announcement lists the broad activity areas as education and health.

How much total funding is estimated for this opportunity?

The estimated total funding listed is $14,300,000.

Is cost sharing or matching required?

No. The announcement indicates there is no cost-sharing or matching requirement.

Who is eligible to apply?

Eligibility is broad for U.S.-based organizations. Eligible applicants include: public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); and for-profit organizations other than small businesses. The eligibility language also explicitly includes faith-based organizations, community-based organizations, regional organizations, and eligible federal agencies.

Are tribal entities and minority-serving institutions included in eligibility?

Yes. The eligibility language explicitly includes Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities (TCCUs), tribal governments and tribal organizations (including federally recognized tribal governments and other tribal government structures), and U.S. territories or possessions.

Are foreign organizations eligible to apply?

No. The FOA explicitly states that foreign organizations are not eligible to apply.

Are foreign components of U.S. organizations allowed?

No. The FOA states that foreign components of U.S. organizations are not allowed.

When was this opportunity posted and when did it close?

The opportunity was posted on May 24, 2011. The original and current closing date listed is July 27, 2011.

Is this opportunity still active?

No. The announcement indicates it was archived on August 27, 2011.

Where are applicants directed to find full details?

The announcement directs applicants to the NIH Grants Guide posting for RFA-CA-11-006 for full details.

Who is listed for technical access issues?

The announcement references NIH Office of Extramural Research webmaster contacts for technical access issues.

What is the overall intent of this FOA in practical terms?

Overall, it is presented as an effort to expand the reach and impact of NCI clinical research by integrating community oncology practices and their patient populations into a national clinical trials infrastructure, with emphasis on effective accrual, faster translation of results into community care, and more equitable participation for minority and underserved populations.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Community Clinical Oncology Program Research Bases (U10)

Previous opportunity: Projects of National Significance American Indian Developmental Disabilities Leadership Development Initiative

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 11 006

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 11 006) also looked into and applied for these:

Funding Opportunity
Community Clinical Oncology Program Research Bases (U10) Apply for RFA CA 11 007

Funding Number: RFA CA 11 007
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Minority Based Community Clinical Oncology Program Groups (U10) Apply for RFA CA 11 008

Funding Number: RFA CA 11 008
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Early Phase Clinical Trials in Imaging and Image Guided Interventions (R21) Apply for PAR 11 216

Funding Number: PAR 11 216
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $250,000
Cancer Target Discovery and Development (CTDD) Network (U01) Apply for RFA CA 11 010

Funding Number: RFA CA 11 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Promoting Engagement in Care and Timely Antiretroviral Initiation Following HIV Diagnosis (R01) Apply for RFA MH 12 060

Funding Number: RFA MH 12 060
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Promoting Engagement in Care and Timely Antiretroviral Initiation Following HIV Diagnosis (R34) Apply for RFA MH 12 061

Funding Number: RFA MH 12 061
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $225,000
High End Instrumentation Grant Program (S10) Apply for PAR 11 228

Funding Number: PAR 11 228
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Limited Competition Institutional Development Award (IDeA) Program Infrastructure for Clinical and Translational Research IDeA CTRU54 Apply for PAR 11 229

Funding Number: PAR 11 229
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $300,000
Epidemiology of Drug Abuse (R01) Apply for PA 11 230

Funding Number: PA 11 230
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Epidemiology of Drug Abuse (R21) Apply for PA 11 231

Funding Number: PA 11 231
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Epidemiology of Drug Abuse (R03) Apply for PA 11 232

Funding Number: PA 11 232
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $50,000
Probes for Microimaging The Nervous System (SBIR R43/R44) Apply for PA 09 062

Funding Number: PA 09 062
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 11 006", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.